Statins and the BMJ: Lots of lessons, but we still need the data

BMJ (Online)

Volumn 349, Issue , 2014, Pages

  Godlee, Fiona ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

CARDIOVASCULAR RISK; DRUG USE; EDITORIAL; EVIDENCE BASED MEDICINE; HEALTH CARE SYSTEM; HUMAN; MEDICAL LITERATURE; MEDICAL RESEARCH; PATIENT CARE; PEER REVIEW; PRIORITY JOURNAL; PUBLICATION;

EID: 84905457124     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.g5038     Document Type: Editorial

References (8)

1. Abramson JD, Rosenberg HG, Jewell N, Wright JM. Should people at low risk of cardiovascular disease take a statin? BMJ 2013;347:f6123.
2. Malhotra A. Saturated fat is not the major issue. BMJ 2013;347:f6340.
3. Heath I, Evans S, Furberg C, Hippisley-Cox J, Krumholz H, Mulrow C, et al. Report of the independent panel considering the retraction of two BMJ papers. 2 Aug 2014. http://journals.bmj.com/site/bmj/statins/ Final%20report%20of%20the%20independent%20panel%20310714.pdf.
4. Hawkes N. Risks in the balance: the statins row. BMJ 2014;349:g5007.
5. Boseley S. Professor who sparked statins row says government should intervene. Guardian 13 Jun 2014. www.theguardian.com/society/2014/jun/13/ professor-statins-row-government-intervene.
6. Retraction Watch. Panel says BMJ was right to not retract two disputed statin papers. 2014. http://retractionwatch.com/2014/08/01/panel-says-bmj-was- right-to-not-retract-two-disputed-statin-papers.
7. Godlee F. Adverse effects of statins. BMJ 2014;348:g3306.
8. Cholesterol Treatment Trialists' (CTT) Collaborators. The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. Lancet 2012;380:581-90.